Thomas A. Buchholz
#124,588
Most Influential Person Now
Thomas A. Buchholz's AcademicInfluence.com Rankings
Thomas A. Buchholzphilosophy Degrees
Philosophy
#5793
World Rank
#8693
Historical Rank
Logic
#3008
World Rank
#4100
Historical Rank
Download Badge
Philosophy
Thomas A. Buchholz's Degrees
- Masters Medicine University of Texas Medical Branch
- Bachelors Biology University of Texas at Austin
Similar Degrees You Can Earn
Why Is Thomas A. Buchholz Influential?
(Suggest an Edit or Addition)Thomas A. Buchholz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Future of cancer incidence in the United States: burdens upon an aging, changing nation. (2009) (1490)
- Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. (1999) (1301)
- Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. (2005) (1123)
- Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. (2013) (1069)
- Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. (2014) (671)
- Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). (2009) (615)
- Cyclin E and survival in patients with breast cancer. (2002) (588)
- Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. (2006) (561)
- Risk of cardiac death after adjuvant radiotherapy for breast cancer. (2005) (535)
- American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. (2010) (524)
- WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells (2007) (502)
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. (2011) (439)
- High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. (2009) (426)
- Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. (2009) (397)
- Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. (2005) (383)
- Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. (2017) (383)
- Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. (2000) (374)
- Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. (2014) (334)
- Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. (2007) (329)
- Inflammatory Breast Cancer: The Disease, the Biology, the Treatment (2010) (318)
- Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). (2009) (315)
- Delayed-Immediate Breast Reconstruction (2004) (314)
- Radiation field design in the ACOSOG Z0011 (Alliance) Trial. (2014) (306)
- Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. (2004) (295)
- Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. (2019) (294)
- Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. (2005) (288)
- Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial (2005) (285)
- Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. (2008) (283)
- Chemosensitization and radiosensitization of tumors by plant polyphenols. (2005) (267)
- Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery (2007) (262)
- Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. (2004) (259)
- Classifying local disease recurrences after breast conservation therapy based on location and histology (2002) (243)
- Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. (2012) (242)
- Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression. (2016) (228)
- Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. (2007) (227)
- Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. (2008) (219)
- Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. (2003) (218)
- Cardiac morbidity of adjuvant radiotherapy for breast cancer. (2005) (215)
- Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. (2014) (213)
- Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. (2015) (206)
- Effect of delay in radiation in the combined modality treatment of breast cancer. (1993) (205)
- Positive surgical margins and ipsilateral breast tumor recurrence predict disease‐specific survival after breast‐conserving therapy (2003) (205)
- Trastuzumab-related cardiotoxicity among older patients with breast cancer. (2013) (202)
- Long-term complications associated with breast-conservation surgery and radiotherapy (2002) (199)
- MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells (2011) (197)
- Biphasic metaplastic sarcomatoid carcinoma of the breast. (2006) (192)
- Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. (2008) (191)
- Wnt/β-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line (2007) (189)
- Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. (2002) (185)
- Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma (2003) (179)
- The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. (2006) (176)
- The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. (2001) (175)
- Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells (2010) (167)
- Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline. (2014) (162)
- The impact of pregnancy on breast cancer outcomes in women ≤35 years (2009) (158)
- Correction for Woodward et al., WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells (2007) (154)
- Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. (2008) (152)
- Breast conservation after neoadjuvant chemotherapy (2005) (149)
- Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. (1998) (148)
- Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis (2016) (146)
- Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma (2006) (144)
- Chemotherapy‐Induced Apoptosis and Bcl‐2 Levels Correlate with Breast Cancer Response to Chemotherapy (2003) (144)
- Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. (2001) (143)
- Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. (2012) (143)
- Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. (2003) (143)
- Inflammatory breast cancer (IBC) and patterns of recurrence (2007) (142)
- Practical Guidelines for Repair of Partial Mastectomy Defects Using the Breast Reduction Technique in Patients Undergoing Breast Conservation Therapy (2007) (141)
- Radiation therapy for early-stage breast cancer after breast-conserving surgery. (2009) (139)
- Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy. (1994) (134)
- Low locoregional failure rates in selected breast cancer patients with tumor‐positive sentinel lymph nodes who do not undergo completion axillary dissection (2007) (132)
- Adoption of intensity-modulated radiation therapy for breast cancer in the United States. (2011) (131)
- Inflammatory breast cancer: what we know and what we need to learn. (2012) (129)
- Accumulation of the common mitochondrial DNA deletion induced by ionizing radiation (2004) (128)
- Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis (2014) (128)
- Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. (2013) (127)
- Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. (2011) (127)
- The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? (2010) (127)
- Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. (2011) (126)
- Improvement in breast cancer outcomes over time: are older women missing out? (2011) (126)
- A Management Algorithm and Practical Oncoplastic Surgical Techniques for Repairing Partial Mastectomy Defects (2008) (123)
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing Trial (2011) (122)
- Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. (2008) (121)
- Trends for inflammatory breast cancer: is survival improving? (2007) (120)
- Physician variation in management of low-risk prostate cancer: a population-based cohort study. (2014) (118)
- Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. (2005) (118)
- Prognostic significance of phosphorylated P38 mitogen‐activated protein kinase and HER‐2 expression in lymph node‐positive breast carcinoma (2004) (118)
- Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. (2014) (117)
- Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy (2007) (116)
- Feasibility of Breast Preservation in the Treatment of Occult Primary Carcinoma Presenting With Axillary Metastases (2001) (115)
- Dosimetric analysis of intact breast irradiation in off-axis planes. (1997) (114)
- Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a monte carlo simulation study (2009) (114)
- Squamous cell carcinoma of the breast. (2005) (112)
- A survey of current clinical practice of permanent prostate brachytherapy in the United States. (1998) (111)
- Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. (2001) (108)
- Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early (2011) (108)
- Improving local control with breast‐conserving therapy (2005) (105)
- Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. (2009) (102)
- Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. (2005) (102)
- Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline‐based neoadjuvant chemotherapy in patients with breast carcinoma (2002) (101)
- Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2 (2002) (101)
- Neoadjuvant chemotherapy for breast carcinoma (2003) (98)
- Histone Deacetylase Inhibitors Stimulate Dedifferentiation of Human Breast Cancer Cells Through WNT/β‐Catenin Signaling (2012) (98)
- Multidisciplinary management of breast cancer concurrent with pregnancy. (2002) (98)
- The Nuclear Transcription Factor κB/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer (2005) (97)
- Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer (2012) (97)
- Global Gene Expression Changes During Neoadjuvant Chemotherapy for Human Breast Cancer (2002) (97)
- Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. (2015) (96)
- Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. (2001) (95)
- Hazard of Recurrence among Women after Primary Breast Cancer Treatment—A 10-Year Follow-up Using Data from SEER-Medicare (2012) (95)
- Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer. (2014) (94)
- Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer. (2011) (93)
- Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. (2005) (93)
- Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. (2002) (92)
- Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. (2011) (92)
- Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer. (2011) (91)
- Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy. (2016) (91)
- Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy (2012) (90)
- A prospective trial of preoperative chemotherapy in resectable breast cancer: Predictors of breast-conservation therapy feasibility (2002) (89)
- Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection: Results of the ACOSOG Z0010 Trial (2012) (89)
- Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. (2003) (89)
- Impact of Chemotherapy Sequencing on Local-Regional Failure Risk in Breast Cancer Patients Undergoing Breast-Conserving Therapy (2013) (88)
- Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. (2007) (87)
- Immediate Breast Reconstruction can Impact Postmastectomy Irradiation (2005) (87)
- Racial disparities in the use of radiotherapy after breast‐conserving surgery: A national Medicare study (2010) (86)
- Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery. (2012) (85)
- The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. (2006) (84)
- The impact of age on outcome in early-stage breast cancer. (2011) (84)
- Presentation, management and outcome of axillary recurrence from breast cancer. (2000) (84)
- Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. (2009) (81)
- A custom three-dimensional electron bolus technique for optimization of postmastectomy irradiation. (2001) (81)
- Controversies regarding the use of radiation after mastectomy in breast cancer. (2002) (81)
- A case–control study of unilateral and bilateral breast carcinoma patients (2001) (80)
- Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis (2015) (80)
- Effectiveness of radiation therapy in older women with ductal carcinoma in situ. (2006) (79)
- Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. (2001) (78)
- Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. (1998) (78)
- Automatic segmentation of whole breast using atlas approach and deformable image registration. (2009) (76)
- Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. (2005) (74)
- Present-Day Locoregional Control in Patients with T1 or T2 Breast Cancer with 0 and 1 to 3 Positive Lymph Nodes After Mastectomy Without Radiotherapy (2010) (74)
- Paget’s Disease of the Breast: There Is a Role for Breast-Conserving Therapy (2005) (74)
- Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. (2007) (74)
- Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. (2006) (74)
- International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013). (2011) (74)
- Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. (2009) (73)
- Chest Wall Recurrence After Mastectomy Does Not Always Portend a Dismal Outcome (2003) (72)
- Clinical outcome of patients with lymph node‐negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry (2005) (72)
- Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy (2007) (72)
- Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. (2011) (71)
- Even Low-level HER2 Expression May be Associated With Worse Outcome in Node-positive Breast Cancer (2009) (71)
- Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells (2010) (71)
- Metaplastic Sarcomatoid Carcinoma of the Breast With Absent or Minimal Overt Invasive Carcinomatous Component: A Misnomer (2005) (70)
- Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. (2006) (70)
- Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025. (2016) (70)
- Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer (2016) (70)
- Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer. (2013) (69)
- Population‐based analysis of occult primary breast cancer with axillary lymph node metastasis (2010) (68)
- T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. (2004) (68)
- Breast cancer multifocality and multicentricity and locoregional recurrence. (2013) (67)
- MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation (2012) (67)
- Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome (2011) (67)
- Cost and Complications of Local Therapies for Early-Stage Breast Cancer (2017) (66)
- Completion of adjuvant radiation therapy among women with breast cancer (2008) (66)
- Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach. (2009) (65)
- Simvastatin Radiosensitizes Differentiated and Stem‐Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients Treated With Postmastectomy Radiation (2014) (65)
- Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers (2012) (64)
- Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. (2013) (64)
- Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer. (2011) (64)
- Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison. (2007) (64)
- Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. (2004) (63)
- Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium. (2000) (63)
- Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. (2006) (63)
- Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. (2012) (62)
- Risk of hypothyroidism in older breast cancer patients treated with radiation (2008) (62)
- The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"? (2006) (62)
- A Multidisciplinary Protocol for Planned Skin-Preserving Delayed Breast Reconstruction for Patients with Locally Advanced Breast Cancer Requiring Postmastectomy Radiation Therapy: 3-Year Follow-Up (2011) (62)
- Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities. (2013) (61)
- Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. (2002) (61)
- Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis (2015) (60)
- Prognostic significance of HER‐2 status in women with inflammatory breast cancer (2008) (60)
- miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. (2016) (59)
- Neutron radiotherapy for adenoid cystic carcinoma of the head and neck. (1993) (59)
- Survival of women with inflammatory breast cancer: a large population-based study. (2014) (59)
- Breast conservation therapy as a treatment option for the elderly (2001) (58)
- Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells (2012) (58)
- 130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain (2007) (57)
- The role of fast neutron radiation therapy in the management of advanced salivary gland malignant Neoplasms (1992) (57)
- Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: early assessment predicts clinical response. (2003) (55)
- Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer (2008) (55)
- Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control. (2010) (55)
- Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. (2003) (55)
- Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model (2015) (55)
- Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy (2012) (54)
- Neoplasms of the Breast (2003) (52)
- Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. (2012) (52)
- Identifying factors that impact survival among women with inflammatory breast cancer. (2012) (51)
- Abstract S2-1: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from the ACOSOG Z1071 trial (2012) (51)
- A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls (2004) (51)
- Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin‐based neoadjuvant chemotherapy (2005) (51)
- Classification of Ipsilateral Breast Tumor Recurrences After Breast Conservation Therapy Can Predict Patient Prognosis and Facilitate Treatment Planning (2011) (51)
- Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: A SEER–Medicare analysis (2013) (50)
- Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. (2014) (50)
- Frequency of first metastatic events in breast cancer: implications for sequencing of systemic and local-regional treatment. (1999) (50)
- Multifocality and multicentricity in breast cancer and survival outcomes. (2012) (50)
- Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ (2004) (49)
- Significantly higher pathological complete remission (PCR) rate following neoadjuvant therapy with trastuzumab (H), paclitaxel (P), and anthracycline-containing chemotherapy (CT): Initial results of a randomized trial in operable breast cancer (BC) with HER/2 positive disease. (2004) (49)
- Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort. (2009) (49)
- Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. (2007) (48)
- External-beam accelerated partial breast irradiation using multiple proton beam configurations. (2011) (47)
- Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy. (2012) (47)
- Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy (2012) (47)
- Radiation-induced chromatid breaks as a predictor of breast cancer risk. (2001) (47)
- Effective Local Control and Long-Term Survival in Patients with T4 Locally Advanced Breast Cancer Treated with Breast Conservation Therapy (2004) (46)
- African‐American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin‐based chemotherapy (2006) (46)
- Predictors of systemic recurrence and disease‐specific survival after ipsilateral breast tumor recurrence (2005) (46)
- Fertility in Men After Treatment for Stage 1 and 2A Seminoma (2004) (45)
- Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. (2006) (44)
- Impact of evidence‐based clinical guidelines on the adoption of postmastectomy radiation in older women (2011) (44)
- Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer. (2011) (43)
- Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. (1999) (43)
- Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. (2014) (43)
- Immediate breast reconstruction after skin-sparing mastectomy for the treatment of advanced breast cancer: Radiation oncology considerations (2002) (43)
- Principles of radiation oncology in older adults (2010) (43)
- The functional promoter polymorphism (−842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger (2010) (42)
- Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells (2014) (42)
- Incidence of brain metastases as a first site of recurrence among women with triple receptor–negative breast cancer (2012) (42)
- A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up. (2011) (41)
- Staging and Classification (2003) (41)
- Surgical Considerations After Neoadjuvant Chemotherapy: Breast Conservation Therapy. (2015) (41)
- DEAR1 Is a Dominant Regulator of Acinar Morphogenesis and an Independent Predictor of Local Recurrence-Free Survival in Early-Onset Breast Cancer (2009) (40)
- Determinants of patient satisfaction during receipt of radiation therapy. (2013) (40)
- Coexpression of α6β4 Integrin and Guanine Nucleotide Exchange Factor Net1 Identifies Node-Positive Breast Cancer Patients at High Risk for Distant Metastasis (2009) (40)
- Ductal Carcinoma-In-Situ: Long-Term Results of Breast-Conserving Therapy (2000) (40)
- Potential applicability of balloon catheter–based accelerated partial breast irradiation after conservative surgery for breast carcinoma (2004) (39)
- Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses. (2013) (39)
- The role of locoregional therapy in inflammatory breast cancer. (2008) (39)
- Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. (2001) (39)
- Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. (2015) (37)
- Tumor suppressor genes and breast cancer. (1999) (37)
- Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. (2020) (37)
- Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. (2018) (37)
- Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. (2012) (37)
- Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer (2012) (36)
- A method to predict breast cancer stage using Medicare claims (2010) (36)
- Staging of breast cancer in the neoadjuvant setting. (2008) (36)
- TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects (2017) (36)
- Internal mammary lymph nodes: to treat or not to treat. (2000) (36)
- Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. (2015) (35)
- Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma (2005) (35)
- Supraclavicular radiation for breast cancer does not increase the 10‐year risk of stroke (2006) (35)
- Economic Burden of Renal Cell Carcinoma in the US (2011) (35)
- Influence of Neoadjuvant Chemotherapy on Radiotherapy for Breast Cancer (2015) (34)
- Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery (2012) (34)
- Molecular biology and genetics of breast cancer development: a clinical perspective. (2002) (34)
- Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience. (2002) (34)
- Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. (2008) (34)
- Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy (2009) (33)
- Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control? (1999) (33)
- Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. (2008) (33)
- Current clinical coverage of Radiation Therapy Oncology Group-defined target volumes for postmastectomy radiation therapy. (2012) (33)
- Use of postmastectomy radiotherapy in older women. (2008) (33)
- Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy. (2012) (33)
- Prognosis for patients with metastatic breast cancer who achieve a no‐evidence‐of‐disease status after systemic or local therapy (2015) (33)
- Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. (2004) (32)
- Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes (2016) (32)
- The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer. (2004) (32)
- Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. (2004) (32)
- Determinants of practice patterns and quality gaps in lung cancer staging and diagnosis. (2014) (32)
- Feasibility of Breast Conservation Therapy in Metachronous or Synchronous Bilateral Breast Cancer (1999) (32)
- Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance). (2016) (32)
- Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation. (2014) (31)
- Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient? (2008) (31)
- Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. (2004) (30)
- Association of Transforming Growth Factor &bgr; Polymorphism C−509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial (2018) (29)
- Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells (2016) (29)
- Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. (2007) (29)
- Hypothyroidism in older patients with head and neck cancer after treatment with radiation: A population‐based study (2009) (29)
- Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer. (2008) (28)
- Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy (2013) (28)
- Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States (2013) (28)
- Prognostic value of initial clinical disease stage after achieving pathological complete response. (2008) (28)
- Overcoming radiation resistance in inflammatory breast cancer (2010) (27)
- Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy (2015) (27)
- Prognostic Implications of Pathological Lymph Node Status After Preoperative Chemotherapy for Operable T3N0M0 Breast Cancer (2000) (27)
- Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study. (2014) (27)
- Incidence of and survival following brain metastases among women with inflammatory breast cancer. (2010) (27)
- Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. (2007) (27)
- Nuclear factor-&kgr;B as a predictor of treatment response in breast cancer (2003) (27)
- Longitudinal analysis of patient‐reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole‐breast irradiation (2016) (27)
- Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy. (2003) (26)
- Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. (2000) (26)
- Prognostic significance of occult axillary lymph node metastases after chemotherapy‐induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer (2009) (26)
- MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells (2016) (26)
- Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome (2010) (26)
- Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits? (2013) (26)
- Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged ≤55 years (2008) (25)
- Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy (2006) (25)
- Erratum: WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, 2, (618-623) DOI: 10.1073/pnas.0606599104) (2007) (24)
- Are ATM mutations 7271T→G and IVS10-6T→G really high-risk breast cancer-susceptibility alleles? (2005) (24)
- Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. (2010) (24)
- A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer. (2017) (24)
- Radiation therapy as an adjuvant treatment after sentinel lymph node surgery for breast cancer. (2003) (23)
- Coronary artery dosimetry in intact left breast irradiation. (2001) (23)
- Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy (2012) (23)
- Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial. (2019) (23)
- Anthracycline regimen adherence in older patients with early breast cancer. (2012) (23)
- Baseline utilization of breast radiotherapy before institution of the Medicare practice quality reporting initiative. (2009) (23)
- Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy (2010) (23)
- The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. (2012) (23)
- The use of bevacizumab among women with metastatic breast cancer: A survey on clinical practice and the ongoing controversy (2012) (23)
- Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base. (2016) (22)
- Cost‐effectiveness of posttreatment surveillance after radiation therapy for early stage seminoma (1998) (22)
- Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation. (2010) (22)
- Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and doxorubicin-based chemotherapy for breast cancer. (2011) (22)
- Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer (2012) (22)
- Breast cancer regional radiation fields for supraclavicular and axillary lymph node treatment: is a posterior axillary boost field technique optimal? (2008) (22)
- Genetic variant rs16430 6bp > 0bp at the microRNA‐binding site in TYMS and risk of sporadic breast cancer risk in non‐hispanic white women aged ≤55 years (2015) (21)
- Multifocality and multicentricity in breast cancer and survival outcomes. (2012) (21)
- Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy. (2017) (21)
- Dose modification factors for 192Ir high‐dose‐rate irradiation using Monte Carlo simulations (2006) (21)
- Is partial breast irradiation a step forward or backward? (2005) (21)
- Other Primary Malignancies in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation Therapy (2013) (20)
- Finding our sensitive patients. (1999) (20)
- Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. (2011) (20)
- Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. (2015) (20)
- Inflammatory breast cancer: current concepts in local management. (2005) (20)
- Utilization of Surgery, Chemotherapy, Radiation Therapy, and Hospice at the End of Life for Patients Diagnosed With Metastatic Melanoma (2015) (20)
- Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation (2014) (20)
- Significant increased recurrence rates among breast cancer patients with HER2-positive, T1a,bN0M0 tumors. (2009) (20)
- Fast neutron radiotherapy. The University of Washington experience. (1994) (20)
- Radiotherapy and survival in breast cancer (2011) (19)
- 18F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy (2013) (19)
- Verification of tangential breast treatment dose calculations in a commercial 3D treatment planning system (2001) (19)
- Factors associated with radiation therapy incidents in a large academic institution. (2015) (19)
- Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer (2011) (18)
- Statistical modeling approach to quantitative analysis of interobserver variability in breast contouring. (2014) (17)
- Molecular predictors of locoregional recurrence in breast cancer: ready for prime time? (2010) (17)
- Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously (2008) (17)
- Sonography and Sonographically Guided Needle Biopsy of Internal Mammary Nodes in Staging of Patients With Breast Cancer. (2015) (17)
- Comparison of Local Recurrence and Distant Metastases Between Breast Cancer Patients After Postmastectomy Radiotherapy With and Without Immediate TRAM Flap Reconstruction (2008) (17)
- Increasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States. (2014) (16)
- Hospital Case Volume Is Associated With Improved Survival for Patients With Metastatic Melanoma (2016) (16)
- Radiation treatments after breast-conserving therapy for elderly patients. (2013) (16)
- Breast-conservation therapy in early-stage breast cancer patients with a positive family history (2002) (16)
- 2097 A dose-volume analysis of permanent transperineal prostate brachytherapy (1997) (16)
- Fast Neutron Radiation for Recurrent Pleomorphic Adenomas of the Parotid Gland (1992) (15)
- The lateral decubitus breast boost: description, rationale, and efficacy. (2008) (15)
- The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer (2015) (15)
- Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform. (2016) (15)
- Nuclear factor-kappa B as a predictor of treatment response in breast cancer. (2003) (15)
- Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis (2017) (14)
- Hypofractionated breast radiation: preferred standard of care? (2013) (14)
- Preparing for the future of radiation oncology. (2007) (14)
- Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor‐positive progesterone receptor‐positive disease in very early stage breast cancer (2011) (14)
- Partial breast irradiation--is it ready for prime time? (2003) (14)
- Radiation Treatments May Contribute to the Development of Cardiac Dysfunction in Breast Cancer Patients Treated with Chemotherapy and Trastuzumab (2008) (13)
- Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control (2011) (13)
- Effects of variable placement of superior tangential/supraclavicular match line on dosimetric coverage of level III axilla/axillary apex in patients treated with breast and supraclavicular radiotherapy. (2009) (13)
- Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? (2007) (13)
- A clinical perspective on regional nodal irradiation for breast cancer. (2017) (13)
- Boron neutron capture enhanced fast neutron radiotherapy for malignant gliomas and other tumors (1997) (13)
- Abstract S6-02: Long-term prognostic value of residual cancer burden (RCB) classification following neoadjuvant chemotherapy (2013) (13)
- Accelerated partial breast irradiation: Current status with a focus on clinical practice (2019) (13)
- Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study. (2003) (13)
- Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit (2014) (12)
- Completion of adjuvant radiation therapy among women with breast cancer (Cancer (2008) 113, (22-29)) (2008) (12)
- Multidisciplinary Management of Locoregional Recurrent Breast Cancer. (2020) (12)
- Economic Burden of Renal Cell Carcinoma (2012) (12)
- Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation. (2017) (12)
- Enhancement of fast neutron beams with boron neutron capture therapy. A mechanism for achieving a selective, concomitant tumor boost. (1994) (12)
- Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant? (2012) (12)
- S2-1: Partial Breast Brachytherapy Is Associated with Inferior Effectiveness and Increased Toxicity Compared with Whole Breast Irradiation in Older Patients. (2011) (12)
- Utilization and Outcomes of Breast Brachytherapy in Younger Women. (2015) (12)
- Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant. (2000) (12)
- Carcinoma of the male breast (2000) (11)
- Practical Radiation Oncology (2015) (11)
- Concomitant boron-neutron capture therapy during fast-neutron irradiation of a rat glioma. (1994) (11)
- Aldehyde Dehydrogenase1 Immunohistochemical Staining in Primary Breast Cancer Cells Independently Predicted Overall Survival But Did Not Correlate with the Presence of Circulating or Disseminated Tumors Cells (2014) (11)
- Tamoxifen-induced thrombocytopenia. (1999) (11)
- Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. (2006) (11)
- Radiosensitivity is predicted by DNA end-binding complex density, but not by nuclear levels of band components. (2004) (11)
- Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy (2006) (10)
- Postoperative Radiation Therapy after Nipple‐Sparing or Skin‐Sparing Mastectomy: A Survey of European, North American, and South American Practices (2017) (10)
- Metastatic Tumor Volume and Extranodal Tumor Extension: Clinical Significance in Patients With Stage II Breast Cancer. (2015) (10)
- Lobectomy, sublobar resection, and stereotactic radiation for early-stage non-small cell lung cancers in the elderly. (2014) (9)
- Abstract P5-14-19: Radiation field design on the ACOSOG Z0011 trial (2013) (9)
- Internal mammary node radiation: a proposed technique to spare cardiac toxicity. (2009) (9)
- Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case–control study (2012) (9)
- Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement. (2019) (9)
- Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival (2010) (9)
- Controversies over the role of radiation therapy for ductal carcinoma in situ (2008) (9)
- Outcomes and Predictive Factors for Salvage Therapy After Local–Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy (2013) (8)
- Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer (2012) (8)
- Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment (2014) (8)
- Hypofractionated Whole Breast Irradiation Results in Less Acute Toxicity and Improved Quality of Life at Six Months Compared to Conventionally Fractionated Whole Breast Irradiation: Results of a Randomized Trial (2014) (8)
- Predicting Radiosensitivity Using DNA End-Binding Complex Analysis (2004) (8)
- Survival and cost-effectiveness of hospice care for metastatic melanoma patients. (2014) (8)
- Disparities in hospice utilization among American Indian Medicare beneficiaries dying of cancer. (2014) (8)
- A comparison of 18-MV and 6-MV treatment plans using 3D dose calculation with and without heterogeneity correction. (1999) (8)
- The 21-Gene Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer Treated on SWOG S8814 (2016) (7)
- TP53 overexpression in radiation-induced osteosarcoma of the rabbit mandible. (1999) (7)
- Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. (2006) (7)
- Correlates and Effect of Suboptimal Radiotherapy in Women With Ductal Carcinoma In Situ or Early Invasive Breast Cancer (2009) (7)
- A Population-Based Study of the Quality of Care in the Diagnosis of Large (≥5 cm) Soft Tissue Sarcomas (2012) (7)
- Comparative effectiveness of five treatment strategies for early-stage non-small cell lung cancer in the elderly. (2012) (7)
- Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique. (2015) (7)
- Radiation treatment improves local-regional control and survival in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy (2003) (7)
- Breast Cancer Biology (2003) (7)
- Diseases of the Breast (2012) (7)
- Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project (2008) (6)
- Proceedings of the First International Inflammatory Breast Cancer Conference (2010) (6)
- Radiation therapy after breast-conserving surgery: does hospital surgical volume matter? A population-based study in Taiwan. (2012) (6)
- Natural History and Prognostic Markers (2003) (6)
- Evidence for change in prognostic stratification of breast tumor subtypes. (2010) (6)
- Rate of radiation therapy events in a large academic institution. (2013) (6)
- Identifying the “sentinel lymph nodes” for arm drainage as a strategy for minimizing the lymphedema risk after breast cancer therapy (2009) (6)
- Now and Later? The Sticky Question of Lymph Node Management in Patients Receiving Preoperative Chemotherapy (2005) (6)
- Local-regional control in breast cancer patients with a possible genetic predisposition. (2000) (6)
- Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla. (2014) (6)
- Chapter 17 – The Breast (2010) (6)
- Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation (2016) (5)
- Optimizing Patient Positioning to Reduce Variation in the Measurement of Breast Cancer-Related Lymphedema. (2019) (5)
- RNA yield from needle biopsies for cDNA microarray analysis of breast cancer prior to neoadjuvant chemotherapy (2001) (5)
- Oral PresentationVariability of Target and Normal Structure Delineation for Breast-Cancer Radiotherapy: A RTOG Multi-Institutional and Multi-Observer Study (2007) (5)
- Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. (2021) (5)
- Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction (2013) (5)
- Treatment of adenoid cystic carcinoma of the salivary gland, a three-field technique. (1990) (5)
- Advances in radiation treatments of breast cancer. (2004) (5)
- Lung carcinoma development after radiotherapy for breast carcinoma (2003) (5)
- A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer (2018) (5)
- Excellent Locoregional Control in Inflammatory Breast Cancer with a Personalized Radiotherapy Approach. (2019) (5)
- Mucinous Breast Carcinoma: Occult Multifocality/Multicentricity in a Favorable Disease. (2009) (5)
- High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy (2006) (5)
- Local-regional Recurrence with and without Radiation after Neoadjuvant Chemotherapy and Mastectomy for T1-2/N0-1 Breast Cancer Patients (2008) (4)
- Intraoperative radiotherapy for early breast cancer (2010) (4)
- Locoregional Outcomes and Radiotherapy Response in Patients with Triple-negative Breast Cancer (2009) (4)
- Integration of Radiation Therapy and Systemic Therapy for Breast Cancer (2006) (4)
- Introduction: locally advanced breast cancer. (2009) (4)
- A phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis: ACOSOG Z1071. (2010) (4)
- Abstract PD03-06: Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with post-mastectomy radiation (2012) (4)
- Quantitative 3-Dimensional Photographic Assessment of Breast Cosmesis After Whole Breast Irradiation for Early Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial (2020) (4)
- Management of Metastatic Breast Cancer (2003) (4)
- Oncology Scan – February 1, 2012 (2012) (4)
- Clinically-relevant pneumonitis is not increased in breast cancer patients treated with sequential paclitaxel and radiation (2003) (4)
- Radiation after breast conservative surgery or after mastectomy reduces local recurrence and improves overall survival in breast cancer (2006) (3)
- Erratum: Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis (2014) (3)
- Value of adjuvant radiation therapy in breast cancer patients with one to three positive lymph nodes undergoing a modified radical mastectomy and systemic therapy. (2009) (3)
- Use of a matchline dosimetry analysis tool (MDAT) to quantify dose homogeneity in the region between abutting tangential and supraclavicular radiation fields (2010) (3)
- Medullary breast carcinoma: Outcomes and prognosis with the utilization of chemotherapy. (2004) (3)
- Using Discrete-Event Simulation to Promote Quality Improvement and Efficiency in a Radiation Oncology Treatment Center (2017) (3)
- Local-regional recurrence with and without radiation after neoadjuvant chemotherapy and mastectomy for T3N0 breast cancer patients. (2009) (3)
- Bayesian analysis unravels pancreas-cancer adjuvant therapy (2013) (3)
- Global Gene Expression Changes during Neoadjuvant Chemotherapy of Human Breast Cancer: 9:21 AM (14) (2002) (3)
- Abstract P1-17-01: Differences in Survival among Women with Stage III Inflammatory and Non-Inflammatory Locally Advanced Breast Cancer Appear Early: A Large Population Based Study (2010) (3)
- The clinical impact of proliferative high-risk lesions presenting concurrently with ductal carcinoma in situ (DCIS) in patients (pts) treated with breast conserving therapy (BCT) (2005) (3)
- Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. (2016) (3)
- Her2-Neu overexpression does not increase the risk of local-regional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiation (2003) (3)
- Target delineation and treatment planning in breast conserving therapy. (2003) (3)
- Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective Treatment. (2016) (3)
- Initiating a lymphedema screening program for breast cancer patients: Determining variability as a first step towards standardization. (2016) (3)
- Accelerated Partial Breast Irradiation: History, Rationale, and Controversies (2009) (3)
- Abstract S3-07: Complication and economic burden of local therapy options for early breast cancer (2016) (3)
- Lumpectomy With Radiation Versus Mastectomy for Early-Stage Breast Cancer: Value-Based Treatment Considerations (2017) (3)
- Isoseparation curves: a mechanism for optimizing off-axis dose homogeneity of intact breast irradiation. (1998) (3)
- Breast Cancer: Postmastectomy Radiation Therapy, Locally Advanced Disease, and Inflammatory Breast Cancer (2011) (3)
- Increasing the value of radiotherapy in breast cancer. (2021) (2)
- Prevention of Invasive Breast Cancer in Women with Intraductal Carcinoma In Situ (DCIS) (2003) (2)
- Predictors of breast radiotherapy plan modifications: Quality assurance rounds in a large cancer centre (2015) (2)
- Use of a Compression Device to Improve Radiation Boost Dose Coverage of the Tumor Bed for Treatment of Breast Cancer (2008) (2)
- Abstracts of ASTRO scientific papers to be presentedEffect of delay in radiation in the combined modality treatment of breast cancer (1992) (2)
- Abstract 1661: TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects (2016) (2)
- Trastuzumab-related cardiotoxicity among older breast cancer patients. (2012) (2)
- Genitourinary Oncology Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing (2016) (2)
- Cancer Therapy : Preclinical MK-1775 , a Novel Wee 1 Kinase Inhibitor , Radiosensitizes p 53-Defective Human Tumor Cells (2011) (2)
- Disparities in hospice utilization among American Indian Medicare beneficiaries dying of cancer. (2014) (2)
- Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. (2015) (2)
- Sentinel lymph node dissection provides similar local-regional control compared to axillary dissection in patients with node negative breast cancer (2005) (2)
- Should breast conservation be offered to young women with breast cancer? (2011) (2)
- In response to Drs. Harris and Recht: Optimal sequencing of chemotherapy and radiation (1993) (2)
- Impact of chemotherapy timing on local-regional failures in patients with breast cancer undergoing breast-conserving therapy. (2011) (2)
- Pathologic Features Predicting for High Rates of Local-Regional Recurrence after Neoadjuvant Chemotherapy and Radiation Therapy for Breast Cancer (2010) (2)
- Quality Improvement in Prostate Brachytherapy Using Time Driven Activity Based Costing (2015) (2)
- Automating RTOG-defined target volumes for postmastectomy radiation therapy. (2011) (2)
- Limited efficacy and significant toxicities of lapatinib (Lap) plus chemotherapy as neoadjuvant therapy (NAC) for HER2-positive inflammatory breast cancer (IBC) patients (Pts). (2012) (2)
- CONSENSUS STATEMENT: APBI FROM ASTRO (2010) (2)
- Radiation Use and Field Design in Women With Node Positive Breast Cancer Treated With Preoperative Systemic Therapy and Breast Surgery Including Axillary Dissection on a Prospective Clinical Trial ACOSOG Z1071 [Alliance] (2015) (2)
- Impact of low estrogen- and progesterone-receptor expression on survival outcomes in breast cancers previously classified as triple-negative breast cancers. (2011) (2)
- Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy (2005) (2)
- Abstract S2-3: Disparities in the utilization of axillary sentinel lymph node biopsy among black and white patients with node-negative breast cancer from 2002–2007. (2012) (2)
- Effectiveness of Radiation for Prevention of Mastectomy in Older Breast Cancer Patients Treated with Breast Conserving Surgery (2011) (1)
- Preclinical in vivo evaluation of a novel treatment strategy combining a Wee1 inhibitor with radiotherapy. (2010) (1)
- Low local recurrence rate among node negative breast cancer patients with tumor size 5cm and larger treated with surgery and chemotherapy without radiation (2004) (1)
- Field-in-field tangent technique improves radiation dose homogeneity in breast conservation (2003) (1)
- Possible Failure of the LQ Model With Large Fraction Sizes (2013) (1)
- Novel inflammatory breast cancer cell line, MDA-IBC-1 expresses and secretes WISP3, a putative tumor suppressor in inflammatory breast cancer. (2009) (1)
- Validation of a novel staging system for breast cancer patients treated with neoadjuvant chemotherapy. (2016) (1)
- Reply to A. Thomsen et al. (2020) (1)
- Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study. (2021) (1)
- Image Guidance is Associated With Decreased Gastrointestinal Toxicity in Patients Receiving Definitive External Beam Radiation Therapy for Prostate Cancer (2015) (1)
- Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSOG 1071 Clinical Trial (2019) (1)
- Postmastectomy Radiation Treatment Rates as a Quality Measure: An Opportunity for Compliance Through Collaboration (2016) (1)
- Locally advanced breast cancer frequently involves the extra-axillary regional nodes: incidence and treatment impact. (2009) (1)
- Metastatic Lymphoma and Spinal Cord Compression (1994) (1)
- DCIS of the breast: Solving the puzzle (2006) (1)
- Populations of cells exhibiting epithelial-mesenchymal transition (EMT) or stem cell characteristics can be propagated from a single inflammatory breast cancer (IBC) cell line based on culture conditions. (2009) (1)
- Abstract P5-14-08: Prospective phase II study of concurrent capecitabine and radiation demonstrates futility in triple negative chemo-resistant breast cancer (2013) (1)
- Socioeconomic Barriers to Randomized Clinical Trial Retention in Patients Treated with Adjuvant Radiation for Early-Stage Breast Cancer. (2023) (1)
- 2001 : Long-Term Local-Regional Treatment Outcomes for Patients With Inflammatory Breast Cancer (2006) (1)
- How Improved Local-Regional Therapy Impacts Survival (2010) (1)
- Toward Developing Survivorship Care Plans for Breast Cancer Patients at High Risk for Radiation-Related Cardiac Effects (2014) (1)
- Effect of Regional Nodal Irradiation on Overall Survival in Patients With High-risk Invasive Breast Cancer: A National Cancer Data Base Analysis (2016) (1)
- Abstract P3-09-04: AML and MDS after adjuvant chemotherapy: A population based study among older breast cancer patients (2015) (1)
- Effect of the use of immediate reconstruction on the rates of bilateral mastectomy and adjuvant radiation therapy use in women with node-positive breast cancer treated with neoadjuvant chemotherapy on ACOSOG Z1071 (Alliance). (2015) (1)
- The Role of Radiation Therapy in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy (2004) (1)
- Activation of ER-α by DNMT and HDAC inhibitors radiosensitizes ER-α negative breast cancer cells (2007) (1)
- Locoregional R ecurrence P atterns A fter M astectomy a nd Doxorubicin-Base d C hemotherapy: I mplications f or Postoperative I rradiation (2000) (1)
- Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy (2011) (1)
- (S003) Curative-Intent Treatment for Newly Diagnosed Breast Cancer With Limited Metastatic Disease to the Sternum or Mediastinum (2017) (1)
- Obinutuzumab Short Duration Infusion Is Preferred By Healthcare Providers and Has Minimal Impact on Patient-Reported Symptoms Among Patients with Untreated, Advanced Follicular Lymphoma (2021) (1)
- Nijmegen breakage syndrome 1 (NBS1) gene polymorphism and chemotherapy-induced neutropenic fever in breast cancer patients (2007) (1)
- Breast Cancer: Intact and Post Mastectomy (2011) (1)
- A prospective study of concurrent cyclophosphamide/methotrexate/5-flourouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma (2004) (1)
- Patterns and predictors of locoregional recurrence in 469 patients treated with post-mastecomy radiation (2002) (1)
- Over-representation of a polymorphism/missense mutation in the ataxia telangiectasia, mutated (ATM) gene in breast cancer patients versus controls (2001) (1)
- Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy (2013) (1)
- Defining the competing risk of local-regional and distant recurrence in 1,256 patients treated with mastectomy and doxorubicin-based adjuvant chemotherapy. (2004) (1)
- Abstract P3-07-05: Oncotype Dx use and its relationship with chemotherapy administration in the general population (2015) (1)
- Factors associated with breast recurrence in young females treated with breast conservation therapy: how young is young? (2003) (1)
- Improving patient safety: Factors leading to radiation therapy events in a large academic institution. (2013) (1)
- Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status (2004) (1)
- Development of a successful outreach program at M. D. Anderson Cancer Center: a global perspective. (2008) (1)
- Irradiation of the internal mammary lymph nodes for breast cancer (2004) (1)
- Postmastectomy radiation as a component of the multidisciplinary management of breast cancer patients. (2005) (1)
- Advances in Radiation Treatments for Breast Cancers Over the Past 20 Years (2009) (1)
- Patterns of radiation use as a component of breast conservation therapy for noninvasive and invasive breast cancers in united states national comprehensive cancer network (nccn) centers (2003) (1)
- Radiation Therapy for Inflammatory Breast Cancer (2012) (1)
- Reply to: Mastectomy skin flap thickness. (2018) (1)
- Breast Conservation Therapy in the 21st Century (2011) (1)
- Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative. (2022) (1)
- Significant Improvement in Regional Recurrence in Young Patients with Breast Cancer Treated with Comprehensive Nodal Irradiation (2008) (0)
- ABI-007, nanoparticle albumin-bound paclitaxel, enhances tumor radioresponse. (2006) (0)
- Use of fresh assessment of tumor-initiating cells in pleural fluid of breast cancer patients to predict overall survival. (2010) (0)
- Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells (2016) (0)
- Dosimetric Analysis of RTOG-defined Target Volumes for Postmastectomy Radiation Therapy (2010) (0)
- Local-regional therapy following systemic treatment (2014) (0)
- The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1-3 positive axillary nodes after mastectomy (2014) (0)
- Oral Scientific SessionsNijmegen Breakage Syndrome 1 (NBS1) Gene Polymorphism and Overall Survival in Breast Cancer (2017) (0)
- 4–47 Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer (2007) (0)
- Abstract P5-03-05: Histone deacetylase (HDAC)-inhibitor mediated reprogramming drives cancer cells to the pentose phosphate metabolic pathway (2012) (0)
- Clinical Data do not Support the Hypothesis that Irradiation Promotes Biologically Aggressive Local Recurrences through Stromal Activation (2009) (0)
- Use of a tumour bed boost as part of radiotherapy for breast cancer. (2015) (0)
- Evaluating locoregional recurrence in breast cancer. Author's reply (2003) (0)
- Breast Cancer: Overview (2011) (0)
- Oncology Scan e Breast Cancer (2012) (0)
- In response to Drs. Lawrence and Crawford (2003) (0)
- OC-0124: IMRT or 3DCRT and cardiopulmonary mortality risk in the elderly with Eeophageal cancer (2015) (0)
- Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial (2012) (0)
- Radiation Use and Long-Term Survival in Breast Cancer Patients with T1,T2 Primary Tumors and 1–3 Positive Axillary Lymph Nodes (2016) (0)
- A Population-based Study to Assess Utilization of Radiation Therapy at the End of Life Among US Medicare Beneficiaries (2012) (0)
- Breast conservation therapy in T4 locally advanced breast cancer: Effective local control with long-term survival (2004) (0)
- Response to doctor antoniades (1994) (0)
- Outcomes and Predictive Factors for Salvage Therapy After Locoregional Recurrence Following Breast Conserving Therapy With Neoadjuvant Chemotherapy (2012) (0)
- Pretreatment Staging PET/CT in Patients with Inflammatory Breast Cancer Influences Radiation Treatment Field Designs (2011) (0)
- Evaluating the Accuracy of Receipt of Breast Radiation Therapy in the Surveillance, Epidemiology, and End Results Database (2012) (0)
- Nailing the Clavicular Head: Assuring Adequate Coverage of the Medial/Inferior Aspect of the Supraclavicular Space in Patients Receiving Regional Nodal Radiation Therapy for Breast Cancer. (2022) (0)
- SU‐E‐T‐776: External Beam Accelerated Partial Breast Irradiation Using Intensity Modulated Proton Therapy (IMPT) (2011) (0)
- Cardiac monitoring during adjuvant trastuzumab-based chemotherapy among older breast cancer patients. (2013) (0)
- 1–39 Locoregional Recurrence Risks in Elderly Breast Cancer Patients Treated With Mastectomy Without Adjuvant Radiotherapy (2006) (0)
- How does biology affect local therapy decisions (2012) (0)
- Honoring the Past and Looking to the Future: Current Issue Marks the End of S. Eva Singletary's Tenure as Editor-in-Chief of Breast Diseases (2010) (0)
- Abstract P3-17-03: Raising the level of cancer care around the world: The feasibility and perceived benefit of a virtual breast tumor board (2022) (0)
- Improved Survival Using IMRT in Head-and-Neck Cancers: A SEER-Medicare Analysis (2013) (0)
- Abstract 3087: MicroRNA 141: A novel regulator of brain metastasis from breast cancer (2015) (0)
- Determinants of Patient Satisfaction for Patients Receiving Radiation Therapy (2012) (0)
- 1st Annual Oncology Update: Advances and Controversies (2001) (0)
- SU‐FF‐T‐196: Evaluation of the Dose Within the Abutment Region Between Tangential and Supraclavicular Fields for Various Breast Irradiation Techniques (2005) (0)
- The Joint Commission is granting your organization an accreditation decision of Accredited for all services surveyed under the applicable manual(s) noted below (2014) (0)
- Herceptin Plus Chemotherapy Combination in Preoperative Regimen May Offer Clinical Benefit in Early Stage Breast Cancer (2005) (0)
- Postmastectomy Radiation Therapy After Positive Sentinel Lymph Node Biopsy and Completion Axillary Lymph Node Dissection (2014) (0)
- Abstract 5044: Radiation modulates expression of microRNAs in breast cancer cell lines grown under adherent and stem cell promoting culture conditions (2012) (0)
- Comparison of pathological risk factors for postmastectomy local-regional recurrence after neoadjuvant versus adjuvant chemotherapy for patients not treated with radiation (2001) (0)
- Reply to P.G. Tsoutsou et al and O. Kaidar-Person et al. (2013) (0)
- Enhancement of in vivo neutron Radiation of a rat glioma through concomitant boron neutron capture therapy (1993) (0)
- Impact of IMRT Use on Survival of Patients With Head-and-Neck Cancer Treated With Radiation: A SEER-Medicare Analysis (2014) (0)
- SEQUENCING OF CHEMOTHERAPY AND RADIATION THERAPY. AUTHORS' RESPONSE (1994) (0)
- Abstract P2-11-02: Three-year outcomes with hypofractionated (HF) versus conventionally fractionated (CF) whole breast irradiation (WBI) (2018) (0)
- Complementing Ipsilateral Breast Tumor Recurrence (IBTR!) Estimates With the 21-Gene Recurrence Score (RS) in Early-Stage, Hormone Receptor-Positive, HER2-Normal, Lymph Node-Negative Breast Cancers (2013) (0)
- Outcomes of Curative-Intent Treatment for Breast Cancer Patients Presenting with Sternal or Mediastinal Involvement (2017) (0)
- Poster ViewingDevelopment of a Novel Magnetically Optimized Beam Delivery System for External Beam Therapy Using Very High Energy Electrons (2017) (0)
- Incidence and characteristics of breast cancer following a diagnosis of ductal carcinoma in situ. (2013) (0)
- Radiosensitivity can be predicted by DNA-end binding complex analysis (2003) (0)
- Abstract P2-09-02: Validation of a Novel Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy (2010) (0)
- Abstract 3281: Functional evaluation of response to targeted therapy in HER2 overexpressing inflammatory breast cancer (IBC) patients using positron emission mammography (PEM) (2010) (0)
- Changes i n t he 2 003 A merican J oint C ommittee o n C ancer Staging f or B reast C ancer D ramatically A ffect S tage-Specific Survival (2003) (0)
- Postmastectomy Radiation Therapy in Stage II-III Breast Cancer Patients <35 Years Old Treated with Doxorubicin-based Neoadjuvant Chemotherapy and Mastectomy (2005) (0)
- Accelerated partial breast irradiation. (2007) (0)
- 2063 Predicting outcome in patients with locoregionally recurrent breast carcinoma after mastectomy (1999) (0)
- Risk of Hypothyroidism in Older Breast Cancer Patients Treated With Radiotherapy (2007) (0)
- James Daniel Cox, MD, FASTRO, FACR. (2019) (0)
- Brachytherapy vs Whole-Breast Irradiation for Breast Cancer—Reply (2012) (0)
- S006) Using Quantitative 3D Metrics of Breast Cosmesis to Compare Fractionation Regimens for Whole Breast Irradiation (2016) (0)
- In reply to Drs. Madhavan and Pervez (2004) (0)
- Effects of Natural Polyphenols on Chemoradiotherapy in Cancer (2010) (0)
- Prospective Analysis of Carotid Flow in Breast Cancer Patients Treated with Supraclavicular Irradiation Eight or More Years Prior to Study: No Increase in Ipsilateral Carotid Stenosis after Radiation (2005) (0)
- Systemic Therapy of Breast Cancer (2003) (0)
- Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis (2021) (0)
- Table 121-4, Breast Cancer Incidence and Mortality Rates by Race or Ethnicity, United States, 1992-1999 (2003) (0)
- Predictors o f L ocal-Regional R ecurrence A fter N eoadjuvant Chemotherapy a nd M astectomy W ithout R adiation (2002) (0)
- P1-04-03: The Effect of Survivin Downregulation on Radiosensitization of Breast Cancer Cell Lines Grown under Adherent and Stem Cell Promoting Culture Conditions. (2011) (0)
- 4-54 HER2 Amplification in Recurrent Breast Cancer Following Breast-Conserving Therapy Correlates With Distant Metastasis and Poor Survival (2007) (0)
- Fifteen-year Results of a Randomized Prospective Trial Comparing Hyperfractionated Versus Once-Daily Chest Wall Radiation After Chemotherapy and Mastectomy for Patients with Locally Advanced Non-Inflammatory Breast Cancer (2005) (0)
- Author reply (0)
- Systemic Adjuvant Therapy (2003) (0)
- Randomized Phase III Clinical Trial to Compare Topical Hyaluronic Acid-based and Petrolatum-based Gels for Radiation Dermatitis in Breast Cancer Patients (2010) (0)
- Postsurgical radiation therapy in patients with complete response to neoadjuvant chemotherapy (2009) (0)
- Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer (2012) (0)
- Implementing value-based cancer care: A multidisciplinary approach to defining breast cancer outcomes. (2016) (0)
- Prospective Randomized Trial of Neoadjuvant Fac vs. TFAC in Patients with Operable Breast Cancer: Impact of Taxane Chemotherapy on Locoregional Control (2009) (0)
- Abstract A55: A novel mediator of brain metastasis from breast cancer (2016) (0)
- Inhibition of IGF-1R Signaling Enhances the Head and Neck Tumor Radioresponse but Fails to Further Improve Tumor Response to Cetuximab and Radiation Therapy In Vivo (2014) (0)
- Locoregional treatment outcomes for patients with ipsilateral supraclavicular metastases at diagnosis of breast cancer (2004) (0)
- Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy (2012) (0)
- Paclitaxel-Based Chemotherapy and Radiotherapy in Breast Cancer Patients (2004) (0)
- Clinically Apparent Internal Mammary Nodal Involvement in Patients with Advanced Breast Cancer - Incidence, Treatment and Outcome (2008) (0)
- Frequency o f F irst M etastatic E vents i n B reast C ancer: Implications f or S equencing o f S ystemic and L ocal-Regional T reatment (1999) (0)
- How Do We Define the Cost of Advanced Technology in Healthcare: A Pilot Study of Proton and Photon Therapy in Oropharyngeal Cancer Patients (2015) (0)
- Psychosocial Aspects of Breast Cancer (2003) (0)
- The impact of IMC nodal drainage on primary breast cancer outcome (2008) (0)
- Predictors of systemic recurrence and impact of local failure among early stage breast cancer patients treated with breast conserving therapy (2001) (0)
- Locoregional Recurrence (LRR) Before and After Implementation of Computed Tomography (CT)-Based Treatment Planning in Post-Mastectomy Radiation Therapy (PMRT) (2007) (0)
- A Weekly Peer Review Quality Assurance Program for Outpatient Radiotherapy (2010) (0)
- Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer (2012) (0)
- Corrections (2007) (0)
- Effect of body mass index on survival outcome among women with early-stage, triple-negative breast cancer. (2011) (0)
- Increased radiation resistance of mouse mammary side population stem/progenitor cells: Role of Wnt/β-catenin signaling (2004) (0)
- 2–40 Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials (2005) (0)
- Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. (2022) (0)
- Abstract 3051: The miR-200 family as a potential therapeutic target in inflammatory breast cancer. (2013) (0)
- Abstract 3340: Expansion of human breast cancer stem /progenitor cell subpopulation through histone deacetylase inhibitors (2011) (0)
- Application of DNA Microarray Technology to Clinical Biopsies of Breast Cancer (2003) (0)
- Effect of Trastuzumab on Locoregional Recurrence in HER2-Positive Breast Cancer According to ER/PR Status (2011) (0)
- PB2083: STUDY CONDUCT AND PATIENT SAFETY DURING THE COVID-19 PANDEMIC: OBSERVATIONS IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA FROM THE GAZELLE TRIAL OF OBINUTUZUMAB SHORT DURATION INFUSION (2022) (0)
- Radiotherapy for early stage favourable breast cancers (2002) (0)
- In regard to postmastectomy radiotherapy. Authors' reply (2004) (0)
- 4-51 ATM Sequence Variants and Risk of Radiation-Induced Subcutaneous Fibrosis After Postmastectomy Radiotherapy (2007) (0)
- The role of postmastectomy radiotherapy in patients with stage II breast cancer (2018) (0)
- 3-43 Radiation Pneumonitis in Breast Cancer Patients Treated With Taxanes: Does Sequential Radiation Therapy Lower the Risk? (2006) (0)
- Triple-Negative/Basal Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer (2010) (0)
- The Effect of Immediate Breast Reconstruction on Postmastectomy Irradiation (2005) (0)
- Figure 121-18, [Comparative survival through 18 years...]. (2003) (0)
- Male breast cancer outcomes: validation and modification of a guideline. (2009) (0)
- 2-41 Descriptions and Outcomes of Insertion Techniques of a Breast Brachytherapy Balloon Catheter in 1403 Patients Enrolled in the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial (2006) (0)
- Breast Brachytherapy in the United States: Utilization Patterns in Older Patients after Breast-conserving Surgery (2009) (0)
- Differential Feeding Tube Placement and Duration With IMRT for Head and Neck Cancer: A SEER-Medicare Analysis (2014) (0)
- (S042) Invasive Lobular Carcinoma Predicts for an Increased Likelihood of Surgical Upstaging Requiring Post-Mastectomy Radiation Therapy (2017) (0)
- EP-1185: Post-operative Irradiation after Nipple-Sparing or Skin-Sparing Mastectomy: An International Survey (2017) (0)
- Abstract P4-04-05: Histone Deacetylase Inhibitors Increase Markers of the Dedifferentiated Cancer Stem Cell Phenotype in Human Breast Cancer Cells (2010) (0)
- Breast cancer multifocality-multicentricity and locoregional recurrance. (2012) (0)
- How does biology affect local therapy decisions? (2012) (0)
- Eliminating Dose To Organs At Risk During Proton Accelerated Partial Breast Irradiation (APBI) Though Temporary, Minimally Invasive Tissue Displacement: Proof Of Principle In Silico (2011) (0)
- Radiation Dose Escalation for Locoregionally Recurrent Breast Cancer (2009) (0)
- LOP09: Biomarkers in Breast Cancer as Preoperative Predictors of Adjuvant Radiation Treatment and Cancer Recurrence—The Dawn of Genomics in Plastic Surgery Practice (2014) (0)
- The Role of Ultrasound of the Regional Nodal Basins in Staging Patients With Triple-Negative Breast Cancer: Implications for Local-Regional Treatment (2014) (0)
- Do Calcium Channel Blockers Adversely Affect Hormonal Treatment of Prostate Cancer Through an Inhibition of Apoptosis (1999) (0)
- MS4-3: Radiation for Patients Treated with Neoadjuvant Chemotherapy. (2011) (0)
- 31st Annual Meeting • American Society of Preventive Oncology, Houston, Texas • March 2–4, 2007 (2007) (0)
- PO-0851: LQ model with large fraction sizes leads to underestimation of isoeffect doses (2014) (0)
- Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification (2005) (0)
- The Influence of Positron Emission Tomography Scanning on Delay in Treatment of Non-Small Cell Lung Cancer (2013) (0)
- Targeting of household air pollution: interpretation of RESPIRE (2011) (0)
- Impact of surgery and radiation of the primary among women with de novo stage IV breast cancer. (2012) (0)
- 4–33 Postmastectomy Radiation and Mortality in Women With T1-2 Node-Positive Breast Cancer (2006) (0)
- 1-47 Effect of Chest X-Rays on the Risk of Breast Cancer Among BRCA1/2 Mutation Carriers in the International BRCA1/2 Carrier Cohort Study: A Report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group (2007) (0)
- SPECIAL SERIES: LOCOREGIONAL MANAGEMENT OF BREAST CANCER (2020) (0)
- The Importance of ATM Mutations and Polymorphisms in Breast Cancer and Radiation Sensitivity (2000) (0)
- Obituary--Kie Kian Ang, MD, PhD, FACR, FASTRO. (2013) (0)
- Trends in Utilization of Intensity Modulated Radiotherapy in Diffuse Large B-cell Lymphoma in the U.S. From 2001 to 2005: A Population-based Study (2011) (0)
- Non-target Tissue Sparing with Passive Scattered Proton Partial-breast Irradiation Planning (2009) (0)
- Improvement in IMRT Quality Assurance Rates: A Quality Improvement Project at a Large Academic Institution (2012) (0)
- Patterns of care and overall survival in the Medicare ovarian cancer population. (2014) (0)
- Abstract P1-17-02: Outcome after Locoregional Recurrence in Patients with Inflammatory Breast Cancer (2010) (0)
- Abstract P6-16-01: The microRNA miR-141 is a key regulator of brain metastasis from breast cancer (2015) (0)
- 160 Importance of radiation therapy for high-risk breast cancer patients treated with high-dose chemotherapy and stem cell transplant (1999) (0)
- Abstract P5-15-03: Patient Characteristics and Clinical Outcome of Patients with Secondary Inflammatory Breast Cancer. M.D. Anderson Cancer Center, Retrospective Review (2010) (0)
- Abstract ES7-3: Indications for radiation treatments after neoadjuvant chemotherapy while awaiting the results of clinical trials (2019) (0)
- Whole Breast Radiotherapy (2010) (0)
- The Role of Radiation for invasive Breast Cancer (2003) (0)
- Brachytherapy vs whole-breast irradiation: trial by data. (2012) (0)
- A novel staging system for disease-specific survival in patients with breast cancer treated with surgery as the first intervention. (2011) (0)
- In reply to Dr. Monsour (2004) (0)
- BNCT as an Adjuvant to Fast Neutron Radiotherapy for Selected Tumor Systems (1996) (0)
- Prevention of Invasive Breast Cancer in Women at Increased Risk (2003) (0)
- Optimal Locoregional Treatment after Neoadjuvant Chemotherapy for Clinically Multifocal or Multicentric Breast Cancer at the Time of Diagnosis (2005) (0)
- Integrating Trastuzumab and Radiation into the Adjuvant Treatments of Breast Cancer (2007) (0)
- Abstract 1461: MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation (2012) (0)
- Quality of Breast Cancer Care in the U.S.: A National Analysis of Medicare Beneficiaries, 2003-2007 (2014) (0)
- Pathologic Complete Response to Neoadjuvant Chemotherapy Plus Trastuzumab Predicts for Improved Survival in Women With HER2-positive Breast Cancer (2012) (0)
- The Radiation Exposure to the Contra Lateral Breast From Portal Images During the Course of Breast Radiotherapy (2007) (0)
- The Future of Radiation Oncology in 2020: How will Changes in the US Population Influence Demand? (2009) (0)
- Quantitative 3D Assessment of Breast Cosmesis After Conventional (CF-WBI) versus Hypofractionated Whole Breast Radiation (HF-WBI): Results of a Randomized Clinical Trial (2019) (0)
- Abstract P3-08-01: Gamma-ray induced mutagen sensitivity and overall survival in young women with breast cancer (2015) (0)
- Radiation Therapy for Locally Advanced Disease (2009) (0)
- Clinical Data Do Not Support the Hypothesis That Irradiation Promotes Biologically Aggressive Local Recurrences through Stromal Activation. (2009) (0)
- Metastatic Tumor Volume and Extranodal Tumor Extension (2015) (0)
- The Radiation Exposure From Portal Images During the Course of Breast Radiotherapy (2008) (0)
- Special Issues Regarding Therapy (2003) (0)
- Brain Metastases in Women with Inflammatory Breast Cancer (IBC): Incidence, Treatment and Outcome. (2009) (0)
- Breast cancer multifocality-multicentricity and survival outcomes. (2012) (0)
- 1–40 Locoregional Recurrence Rates and Prognostic Factors for Failure in Node-Negative Patients Treated With Mastectomy: Implications for Postmastectomy Radiation (2006) (0)
- Use of Breast Reconstruction and Early Complication Rates in a Working-Age, Insured, National Cohort of Breast Cancer Patients Undergoing Mastectomy With and Without Radiation (2013) (0)
- Abstract P4-11-15: Outcomes for Breast Cancer Patients with Isolated Metastasis or Recurrence to the Contralateral Nodal Basins (2010) (0)
- The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty (2009) (0)
- Value-Based Breast Cancer Care (2016) (0)
- 1st annual oncology update: advances and controversies. Steamboat Springs, Colorado, USA, 13-17 February 2001. (2001) (0)
- Locoregional Recurrence Rates in Young Women With Breast Cancer by Treatment Approach (2007) (0)
- Antiepileptic Drug Use Improves Overall Survival in Breast Cancer Patients With Brain Metastases in the Setting of Whole Brain Radiation Therapy (2013) (0)
- Radiation Modality Utilization and Cardiopulmonary Mortality Risk in the Elderly with Esophageal Cancer (2015) (0)
- Gene Expression Profiles Obtained from Fine-Needle Aspirations of Breast Cancer Reliably Identify Routine Prognostic Markers and Reveal Large-Scale Molecular Differences between Estrogen-negative and Estrogen-positive Tumors 1 (2003) (0)
- Breast brachytherapy in the United States: how is this emerging modality being incorporated into the care of older breast cancer patients?. (2009) (0)
- Abstract 4895: P16INK4A, a surrogate marker of HPV infection and prognosis for head and neck cancer, delays DNA damage repair and enhances radiation response (2014) (0)
- Reply to P.G. Tsoutsou et al. (2013) (0)
- Excellent Locoregional Control in Inflammatory Breast Cancer with a Personalized Radiation Therapy Approach (2018) (0)
- In Reply to Dr. Beal et al (2010) (0)
- DCIS of the breast: Solving the puzzle: J.S. Wong, C.M. Kaelin, S.L. Troyan, M.A. Gadd, R. Gelman, S.C. Lester, S.J. Schnitt, D.C. Sgroi, B.J. Silver, J.R. Harris and B.L. Smith.J Clin Oncol2006;24:1031–1036 (2007) (0)
- 1–34 Tamoxifen With or Without Breast Irradiation in Women 50 Years of Age or Older With Early Breast Cancer (2005) (0)
- Long-Term Outcome for Patients with Isolated Supraclavicular Nodal Recurrence After Mastectomy and Doxorubicin-Based Chemotherapy for Breast Cancer (2015) (0)
- Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model (2015) (0)
- The Importance of Radiation Therapy in Improving Survival of Selected Patients with Breast Cancer (2006) (0)
- Prospective Validation of Transforming Growth Factor-Beta (TGF-β) Polymorphism C509T as a Predictor of Radiation-Induced Fibrosis in Early Stage Breast Cancer Patients (2017) (0)
- Comprehensive Post-mastectomy Radiation Therapy (PMRT) in Inflammatory Breast Cancer (IBC) Patients with Limited M1 Disease (2011) (0)
- 3–39 Prospective Evaluation of Concurrent Paclitaxel and Radiation Therapy After Adjuvant Doxorubicin and Cyclophosphamide Chemotherapy for Stage II or III Breast Cancer (2006) (0)
- Breast cancer in the United States: the burden on an aging, changing nation. (2009) (0)
- Survival of women with in fl ammatory breast cancer : a large population-based study † (2014) (0)
- Aldehyde Dehydrogenase1 Immunohistochemical Staining In Breast Cancer Tumor Cells Is Not A Surrogate For Circulating Or Disseminated Tumors Cells (2011) (0)
- Long-term complications associated with breast-conservation surgery and radiotherapy. (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas A. Buchholz?
Thomas A. Buchholz is affiliated with the following schools:
